These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 26889611)
1. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. Haroutounian S; Ratz Y; Ginosar Y; Furmanov K; Saifi F; Meidan R; Davidson E Clin J Pain; 2016 Dec; 32(12):1036-1043. PubMed ID: 26889611 [TBL] [Abstract][Full Text] [Related]
2. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328 [TBL] [Abstract][Full Text] [Related]
3. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. Boehnke KF; Litinas E; Clauw DJ J Pain; 2016 Jun; 17(6):739-44. PubMed ID: 27001005 [TBL] [Abstract][Full Text] [Related]
4. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). Ware MA; Wang T; Shapiro S; Collet JP; J Pain; 2015 Dec; 16(12):1233-1242. PubMed ID: 26385201 [TBL] [Abstract][Full Text] [Related]
5. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. Lake S; Walsh Z; Kerr T; Cooper ZD; Buxton J; Wood E; Ware MA; Milloy MJ PLoS Med; 2019 Nov; 16(11):e1002967. PubMed ID: 31743343 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry. Francis A; Erridge S; Holvey C; Coomber R; Holden W; Rucker J; Platt M; Sodergren M J Pain Palliat Care Pharmacother; 2024 Jun; 38(2):103-116. PubMed ID: 38669060 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain. Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H BMC Musculoskelet Disord; 2017 Aug; 18(1):337. PubMed ID: 28778219 [TBL] [Abstract][Full Text] [Related]
8. Cannabis and Cannabinoids for Chronic Pain. Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880 [TBL] [Abstract][Full Text] [Related]
9. Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain. Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ J Pain; 2019 Jul; 20(7):830-841. PubMed ID: 30690169 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study. Tait MA; Costa DSJ; Campbell R; Norman R; Warne LN; Schug S; Rutherford C PLoS One; 2023; 18(9):e0290549. PubMed ID: 37672515 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study. Eisenberg E; Ogintz M; Almog S J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789 [TBL] [Abstract][Full Text] [Related]
12. Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry. Kawka M; Erridge S; Holvey C; Coomber R; Usmani A; Sajad M; Platt MW; Rucker JJ; Sodergren MH J Clin Pharmacol; 2021 Dec; 61(12):1545-1554. PubMed ID: 34473850 [TBL] [Abstract][Full Text] [Related]
13. Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study. Safakish R; Ko G; Salimpour V; Hendin B; Sohanpal I; Loheswaran G; Yoon SYR Pain Med; 2020 Nov; 21(11):3073-3086. PubMed ID: 32556203 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. Abuhasira R; Schleider LB; Mechoulam R; Novack V Eur J Intern Med; 2018 Mar; 49():44-50. PubMed ID: 29398248 [TBL] [Abstract][Full Text] [Related]
15. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes. Shah A; Craner J; Cunningham JL J Subst Abuse Treat; 2017 Jun; 77():95-100. PubMed ID: 28476279 [TBL] [Abstract][Full Text] [Related]
17. Benefits and adverse effects of cannabis use among adults with persistent pain. Bigand T; Anderson CL; Roberts ML; Shaw MR; Wilson M Nurs Outlook; 2019; 67(3):223-231. PubMed ID: 30616866 [TBL] [Abstract][Full Text] [Related]
18. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Lotan I; Treves TA; Roditi Y; Djaldetti R Clin Neuropharmacol; 2014; 37(2):41-4. PubMed ID: 24614667 [TBL] [Abstract][Full Text] [Related]
19. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain. Taber L; Lynch SY; He E; Ripa SR Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111 [TBL] [Abstract][Full Text] [Related]